Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: IRWIN JAMES FRANKEL who wrote (23535)	4/24/2007 11:51:17 AM
From: Biomaven	Read Replies (2) \| Respond to of 52153

I now recall that post of yours. But I had focused more on the "duty of disclosure" aspect than on the potential for "cross-trading." If this was a law-school exam, I'd raise the interesting possibility that if it were legal for Teva itself to trade MNTA stock based on Teva's information advantage, then it would paradoxically be illegal for a Teva employee to do so (under the misappropriation theory as the employee would be "stealing" the informational advantage from his/her employer). If, however, it were illegal for Teva to trade, then presumably it would also be illegal for an employee of Teva to trade. QED :) Peter